News
Internal mammary lymph node radiation safe over the long term
- Author:
- M. Alexander Otto, MMS, PA
Rates of heart and lung complications very low, with no increased non–breast cancer related mortality with radiation procedure.
News
Better CNS control in children with ALL: ‘Goldilocks’ approach
- Author:
- M. Alexander Otto, MMS, PA
“Because cure rates now exceed 90%, using neurotoxic drugs in non–risk-adapted protocols is unacceptable and a...
News
Internal mammary lymph node radiation safe over the long term
- Author:
- M. Alexander Otto, MMS, PA
But for patients with higher baseline cardiopulmonary risk factors, lower mean heart doses should be used.
News
FDA approves new asparaginase product for leukemia
- Author:
- M. Alexander Otto, MMS, PA
The problem is that about 20% of patients become allergic to the standard option, asparaginase derived from Escherichia coli.
News
Do patients with cancer need a third shot of COVID vaccine?
- Author:
- M. Alexander Otto, MMS, PA
Regulators and policymakers are “keenly aware that physicians and patients alike are anxious to get going and...
News
Huge trial casts doubt on bisphosphonates for breast cancer
- Author:
- M. Alexander Otto, MMS, PA
New results show no difference in disease-free survival, distant disease-free survival, and overall survival.
News
No increase in breast cancer risk with fertility treatments
- Author:
- M. Alexander Otto, MMS, PA
This study “provides the evidence needed to reassure women and couples seeking fertility treatments.”
News
New drug toripalimab improves survival in nasopharyngeal cancer
- Author:
- M. Alexander Otto, MMS, PA
The drug is a monoclonal antibody that blocks programmed cell dealth protein 1 (PD-1).
News
Pregnancy outcomes ‘favorable’ after BRCA breast cancer treatment
- Author:
- M. Alexander Otto, MMS, PA
Pregnancy after treatment for breast cancer with BRCA mutations is safe, researchers say.
News
Pembrolizumab approved for triple-negative breast cancer
- Author:
- M. Alexander Otto, MMS, PA
This is the first breast cancer indication for pembrolizumab.
News
Melanoma experts say ‘no’ to routine gene profile testing
- Author:
- M. Alexander Otto, MMS, PA
This test is not endorsed by the American Academy of Dermatology or National Comprehensive Cancer Network outside of studies.